Business
Jaguar Health Reports Voting Results from January 2023 Special Meeting of Stockholders
All proposals approvedCompany announces 1-for-75 reverse stock split to support compliance with Nasdaq listing standardsShares of Jaguar Health common stock
About this update from Jaguar Health, Inc.
[{"type":"text","content":"All proposals approvedCompany announces 1-for-75 reverse stock split to support compliance with Nasdaq listing standardsShares of Jaguar Health common stock to begin trading on split-adjusted basis on January 23, 2023Patient enrollment expected to complete in Q2 2023 for company's pivotal Phase 3 OnTarget clinical trial of crofelemer for prophylaxis of diarrhea in adult cancer patients receiving targeted therapySAN FRANCISCO, CA / ACCESSWIRE / January 20, 2023 / Jaguar Health, Inc. (NASDAQ:JAGX) (\"Jaguar\" or the \"Company\") today announced the voting results of the Company's Special Meeting of Stockholders (the \"Special Meeting\") held on January 20, 2023 and announced that the Company will effect a reverse stock split of its issued and outstanding voting common stock (\"Common Stock\"), at an exchange ratio of 1-for-75, on Monday, January 23, 2023 (the \"Effective Date\") in order to support the Company's compliance with Nasdaq's listing standards. The Company's Common Stock will begin trading on a split-adjusted basis when the market opens on the Effective Date and will remain listed on The Nasdaq Capital Market under the symbol \"JAGX\". The new CUSIP number for the Company's Common Stock following the reverse stock split is 47010C706.The effectuation of the reverse stock split follows the approval of a proposal submitted to Jaguar stockholders at the Special Meeting. This proposal was approved by the affirmative vote of the holders of a majority of the voting power of the Jaguar Common Stock and the Series F Preferred Stock of the Company outstanding as of the record date for the Special Meeting. Three proposals were submitted to and approved by the stockholders of the Company at the Special Meeting. The proposals are described in detail in the Company's definitive proxy statement on Schedule 14A relating to the Special Meeting filed with the Securities and Exchange Commission on November 28, 2022. Stockholders may obtain a free copy of the proxy statement and other documents filed by Jaguar with the SEC at http://www.sec.gov. The proxy statement is also available on the Company's corporate website.When the reverse stock split becomes effective, every seventy-five (75) shares of the Company's Common Stock immediately prior to the Effective Date shall automatically be reclassified into one (1) share of Common Stock, witho...